Aptus Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Aptus Capital Advisors, LLC
- $12.7 Billion
- Q3 2025
A detailed history of Aptus Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 3,447 shares of ARKG stock, worth $92,689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,447
Previous 3,447
-0.0%
Holding current value
$92,689
Previous $83,000
14.46%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARKG
# of Institutions
296Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio